CJC-1295 Clinical Trials: Registered Studies and Status
As of November 2, 2026, ClinicalTrials.gov lists 1 registered study matching CJC-1295 or its known aliases as an intervention.
Summary
- Registered studies
- 1
- Most advanced phase
- Phase 2
- Recruiting or not yet recruiting
- 0
- Most recent start
- 2005-12
- Most frequent lead sponsor
- ConjuChem (1)
- Most common status
- Terminated
Source: ClinicalTrials.gov, retrieved . Registry searches by name may miss studies that use other identifiers.
Registered studies
| NCT ID | Title | Phase | Status | Enrollment | Start | Lead sponsor |
|---|---|---|---|---|---|---|
| NCT00267527 | A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity | Phase 2 | Terminated | 120 | 2005-12 | ConjuChem |
Method and limitations
- Data source: ClinicalTrials.gov API v2, intervention search.
- Query used:
"CJC-1295" OR "DAC:GRF" - Retrieved: November 2, 2026. Refreshed weekly; changes are reviewed before publication.
- Studies registered only under other names, sponsor codes, or in other registries may be missing.
- A match on name does not mean the study tested this peptide alone; some studies include it as a comparator or combination.
- Status values are reported by sponsors and may be out of date.